IL17A and lung carcinoma: However, there are also conflicting results from mice studies that revealed that in mice with lung cancer and dysbiosis, IL-17 was increasingly produced, which increased PD-1+T cell expression and the recruitment of neutrophils, which resulted in reduced survival and increased the burden of lung tumors [84].